The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

Infectious Diseases of Poverty, published by BMC, is a leading open-access journal dedicated to addressing the critical intersection of infectious diseases and poverty. Since its inception in 2012, this influential journal has contributed significantly to the fields of public health, infectious diseases, and environmental health. With impressive rankings placing it in the top quartile (Q1) across multiple categories—including Infectious Diseases and Public Health, Environmental and Occupational Health—it stands as a vital resource for researchers and practitioners alike. The journal's commitment to accessibility ensures that high-quality research is available to a global audience, fostering collaboration and knowledge sharing. Based in the UK, Infectious Diseases of Poverty aims to publish innovative research that sheds light on the complexities of infectious diseases and their socio-economic determinants, ultimately working to improve health outcomes in vulnerable populations around the world. With its robust impact factor and esteemed standing within the academic community, this journal serves as an essential platform for advancing the understanding and management of infectious diseases related to poverty.

Microbial Risk Analysis, published by Elsevier, is a pivotal academic journal specializing in the intersection of epidemiology, infectious diseases, and medical microbiology. With an ISSN of 2352-3522 and an E-ISSN of 2352-3530, this journal has been contributing to the field since its inception in 2016 and continues to invite groundbreaking research as it converges through 2024. With a respectable impact factor, Microbial Risk Analysis holds a Q3 designation in key categories, showcasing its credibility with ranks such as #48 in Epidemiology and #124 in Infectious Diseases according to Scopus. The journal serves as an essential platform for researchers, professionals, and students alike, aiming to enhance understanding of microbial risks and their public health implications. Although it operates under a subscription model, its contents remain accessible to a broad range of interdisciplinary scholars dedicated to advancing microbial research. For those at the forefront of epidemiological and infectious disease studies, Microbial Risk Analysis represents a crucial resource for disseminating knowledge and fostering collaboration.

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.

Current Research in Parasitology & Vector-Borne Diseases, published by ELSEVIER, is an influential journal dedicated to advancing the understanding of parasitology and vector-borne diseases. With an ISSN of 2667-114X, this journal is highly esteemed in the field, holding a prestigious Q1 quartile ranking in categories such as Animal Science and Zoology, Insect Science, and Parasitology, as well as a notable Q2 ranking in Virology for 2023. The journal's focus spans a crucial intersection of disciplines, offering a platform for innovative research that directly addresses global health challenges posed by parasites and vectors. Researchers benefit from its robust open-access model, which facilitates unrestricted dissemination of knowledge, making essential findings accessible to a wider audience. The journal continues to play a pivotal role in fostering scholarly dialogue and interdisciplinary collaboration within the scientific community, serving as a vital resource for professionals, students, and academicians interested in the dynamic and evolving field of parasitology.

JAVMA - Journal of the American Veterinary Medical Association, a leading publication in the field of veterinary medicine, has been a cornerstone of veterinary research and practice since its inception in 1945. Published by the American Veterinary Medical Association, this esteemed journal provides a vital platform for disseminating innovative studies, clinical findings, and advancements that enhance the welfare of animals and the practice of veterinary medicine. With an impressive impact factor reflecting its scholarly influence and a position in the top quartile (Q2) among veterinary journals, JAVMA is recognized for its rigorous peer-review process and high-quality content. Although the journal does not offer Open Access, it remains accessible through a variety of academic libraries and institutions, making it a crucial resource for researchers, veterinarians, and students dedicated to advancing the field. With a Scopus rank of #92 out of 194 in the general veterinary category, JAVMA is committed to fostering knowledge and discussions that shape the future of veterinary science.

Revista de Salud Ambiental is a prestigious scientific journal dedicated to advancing knowledge in the field of environmental health. Published by the SOC ESPANOLA SANIDAD AMBIENTAL, this Open Access journal has been providing free access to its articles since 2001, ensuring that critical research on environmental influences on public health is widely available to researchers, professionals, and students worldwide. With an ISSN of 1577-9572 and E-ISSN 1697-2791, the journal covers a broad range of topics including environmental toxins, pollution management, and sustainable public health practices. Its commitment to high-quality research is reflected in its rigorous peer-review process, aiming to drive significant advancements in environmental health science. By promoting interdisciplinary collaboration and dissemination of impactful research, Revista de Salud Ambiental plays a vital role in shaping environmental health policies and practices, making it an essential resource for anyone invested in the future of public health.

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

Antibiotics-Basel is a prestigious multidisciplinary journal published by MDPI, dedicated to advancing the field of antibiotic research and management. Since its inception in 2012 as an Open Access publication, the journal has established itself as a vital resource for researchers and professionals, offering an accessible platform for the dissemination of innovative findings in Biochemistry, Infectious Diseases, Microbiology, and Pharmacology. With a solid impact in its category, Antibiotics-Basel holds a Q1 ranking in critical areas such as Pharmacology and Pharmacology, Toxicology and Pharmaceutics, making it an influential journal in its field. The journal publishes high-quality research articles, reviews, and communications that are essential for advancing our understanding of antibiotic mechanisms, resistance, and therapeutic applications. Researchers are invited to submit their manuscript to contribute to this growing body of knowledge and collaborate in the fight against antibiotic resistance and infectious diseases.